Media Releases  – 

BioHorizons Camlog addresses new approaches on immediacy and soft tissue management at the International Osteology Symposium 2023.

BioHorizons Camlog offers an informative Corporate Forum on immediate treatment with CONELOG® Progressive-Line and a workshop session focused on soft tissue management featuring NovoMatrix, the next generation soft tissue augmentation material.

Basel – 23 March 2023. The International Osteology Symposium 2023 will be held from 27 to 29 April 2023, in Barcelona, Spain, and will bring together leading experts in all fields of regeneration offering an exciting programme including a total of 80 presentations and 14 workshops under the Scientific direction of Drs. Pamela K. McClain and Istvan Urban. BioHorizons Camlog is a Gold Partner and offers two educational programmes to the attendees.

On Thursday, 27 April 2023, Dr. Ramón Gómez Meda (Spain), gives insights into a new approach to soft-tissue augmentation around implants using the NovoMatrixTM dermal matrix. He will dive deep into indications, techniques, and clinical cases highlighting soft-tissue augmentation to achieve predictable results with NovoMatrix; participants can benefit from a hands-on training on pig jaws to learn VISTA, tunnel and crestal incision techniques for soft-tissue augmentation.

Later the same day, Dr. Tomas Linkevicius (Lithuania) will lead a Corporate Forum, offering a differentiating approach to immediate implant concepts entitled “Turning contraindication for immediacy into indication”. In his presentation, attendees will have the chance to discuss why immediate implant treatment is often an optimum solution and how to expand the indications for immediacy.

Attendees are invited to visit the BioHorizons Camlog booth 3 and discover the Company’s broad portfolio of innovative and holistic regenerative solutions through its comprehensive line of biomaterials, including bone replacement grafts (allogeneic, porcine, bovine, and synthetic), membranes (porcine, bovine, and synthetic), reconstructive tissue matrices (porcine) and wound dressings (bovine). BioHorizons Camlog has established one of the leading implant companies with a comprehensive portfolio of biomaterials solutions that allows dental professionals to give their patients the best possible treatment.

For more information visit

About BioHorizons Camlog


BioHorizons and Camlog are leading suppliers of premium dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions. They are committed to developing evidence-based and scientifically proven products, as well as continuous education according to highest standards.

Headquartered in the U.S. and Europe, respectively, BioHorizons and Camlog’s geographic positions allow them to efficiently serve direct subsidiaries in the Americas and Western Europe, as well as their entire distribution network in more than 90 countries around the world.

The companies are part of Henry Schein, Inc., a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, Henry Schein’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help to improve operational success and clinical outcomes.

For more information, please visit and



Stefanie Fleige
Director, Corporate Media Relations – EMEA
Phone: +49 172 6433 548

Christina Ritchie
Head Marketing Communication BioHorizons Camlog
Phone: +41 79 593 07 74


Download press release

Download image